Editing Breast cancer (section)

=== Molecular markers ===

==== Metabolic markers ====

Clinically, the most useful metabolic markers in breast cancer are the estrogen and progesterone receptors that are used to predict response to hormone therapy. New or potentially new markers for breast cancer include BRCA1 and BRCA2<ref name="pmid11522269">{{cite journal | vauthors = Duffy MJ | title = Biochemical markers in breast cancer: which ones are clinically useful? | journal = Clinical Biochemistry | volume = 34 | issue = 5 | pages = 347–52 | date = July 2001 | pmid = 11522269 | doi = 10.1016/s0009-9120(00)00201-0}}</ref> to identify people at high risk of developing breast cancer, [[HER-2]],{{medical citation needed|date=May 2018}} and [[SCD1]], for predicting response to therapeutic regimens, and [[urokinase plasminogen activator]], PA1-1 and SCD1 for assessing prognosis.{{medical citation needed|date=May 2018}}